Cell junction proteins: Crossing the glomerular filtration barrier in diabetic nephropathy.


Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
01 Apr 2020
Historique:
received: 15 10 2019
revised: 17 01 2020
accepted: 17 01 2020
pubmed: 22 1 2020
medline: 2 12 2020
entrez: 22 1 2020
Statut: ppublish

Résumé

Diabetic nephropathy as a deleterious complication of diabetes mellitus and an important cause of end-stage renal failure is characterized by changes in the molecular and cellular levels. Cell-cell communication via the gap and tight junctions are involved in the pathogenesis of diseases such as diabetes and kidney failure. Studying cell junctions including gap junctions, tight junctions, and anchoring junctions within the nephron can be used as an early sign of diabetic nephropathy. Furthermore, cell junctions may be an upcoming target by pharmacological methods to improve treatments of diabetic nephropathy and pave the way to introduce promising therapeutic strategies based on cell-cell communications effects and its translation into clinical studies for the treatment of diabetic nephropathy.

Identifiants

pubmed: 31962072
pii: S0141-8130(19)38364-3
doi: 10.1016/j.ijbiomac.2020.01.168
pii:
doi:

Substances chimiques

Cell Adhesion Molecules 0
Membrane Proteins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

475-482

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None.

Auteurs

Aziz Eftekhari (A)

Pharmacology and Toxicology Department, Maragheh University of Medical Sciences, Maragheh, Iran.

Sepideh Zununi Vahed (SZ)

Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Taras Kavetskyy (T)

Drohobych Ivan Franko State Pedagogical University, Drohobych, Ukraine; The John Paul II Catholic University of Lublin, Lublin, Poland.

Maryam Rameshrad (M)

Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran.

Samira Jafari (S)

Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Leila Chodari (L)

Physiology Department, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.

Seyed Mahdi Hosseiniyan (SM)

Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Hossein Derakhshankhah (H)

Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Elham Ahmadian (E)

Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Students Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: ahmadian.elham@yahoo.com.

Mohammadreza Ardalan (M)

Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: ardalan34@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH